|
⚲
|
| Keyboard |
| Nodelman OLEG
✚
|
|
|---|---|
| CIK # | 0001454385 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Macrogenics Inc | 0.0 | ||
| Ironwood Pharmaceuticals Inc | 0.0 | ||
| Atara Biotherapeutics Inc | 0.0 | ||
| Ventrus Biosciences Inc | 0.0 | ||
| Xenon Pharmaceuticals Inc | 0.0 | ||
| Halozyme Therapeutics Inc | 0.0 | ||
| Array Technologies Inc | 0.0 | ||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001454385] | |
| 3 | [0001454385] | |
| 4 | [0001454385] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 2,270,879 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 202,862 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 128,506 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 2,077,779 | $18.00 | 37,400,022 |
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 102,500 | ||
|
Aktis Oncology Inc AKTS
Class A Common Stock · derivative
|
2026-01-12 | Conversion | 86,222 | ||
|
Aktis Oncology Inc AKTS
Class A Common Stock · derivative
|
2026-01-12 | Conversion | 965,190 | ||
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 2,397,500 | ||
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 488,891 | ||
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 997,299 | ||
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 9,913,810 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 144,443 | $18.00 | 2,599,974 |
|
Zymeworks Inc ZYME
Pre-Funded Warrants (right to acquire) · derivative
|
2025-06-26 | Option exercise | 5,086,521 | $0.00 | |
|
Zymeworks Inc ZYME
Common Stock
|
2025-06-26 | Option exercise | 5,086,480 | $0.00 | |
|
Zymeworks Inc ZYME
Common Stock
|
2025-06-26 | Tax withheld | 41 | $12.71 | 521 |
|
Zymeworks Inc ZYME
Common Stock
|
2025-05-19 | Buy | 5,919 | $11.78 | 69,726 |
|
Zymeworks Inc ZYME
Common Stock
|
2025-05-15 | Buy | 49,502 | $11.43 | 565,808 |
|
Zymeworks Inc ZYME
Common Stock
|
2025-04-17 | Buy | 54,760 | $11.52 | 630,835 |
|
Zymeworks Inc ZYME
Common Stock
|
2025-04-16 | Buy | 73,953 | $11.16 | 825,315 |
|
Zymeworks Inc ZYME
Common Stock
|
2025-04-04 | Buy | 196,438 | $11.17 | 2,194,212 |
| showing 20 of 102 most recent transactions | |||||